Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial

por Li, Dou-Dou, Tao, Zhong-hua, Wang, Bi-Yun, Wang, Lei-Ping, Cao, Jun, Hu, Xi-Chun, Zhang, Jian
Publicado 2022

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

por Wang, Bi-Yun, Zhang, Jian, Wang, Jia-Lei, Sun, Si, Wang, Zhong-Hua, Wang, Lei-Ping, Zhang, Qun-Ling, Lv, Fang-Fang, Cao, En-Ying, Shao, Zhi-Min, Fais, Stefano, Hu, Xi-Chun
Publicado 2015

Erratum to: Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

por Wang, Bi-Yun, Zhang, Jian, Wang, Jia-Lei, Sun, Si, Wang, Zhong-Hua, Wang, Lei-Ping, Zhang, Qun-Ling, Lv, Fang-Fang, Cao, En-Ying, Shao, Zhi-Min, Fais, Stefano, Hu, Xi-Chun
Publicado 2015